Shopping Cart
Remove All
Your shopping cart is currently empty
Anticanceragent 193 (compound D3-3) is an inducer of ferritinophagy, ultimately triggering ferroptosis. This compound stimulates the production of lipid ROS and significantly enhances the release of ferrous ions in colorectal cancer cells through an autophagy-dependent mechanism.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Anticanceragent 193 (compound D3-3) is an inducer of ferritinophagy, ultimately triggering ferroptosis. This compound stimulates the production of lipid ROS and significantly enhances the release of ferrous ions in colorectal cancer cells through an autophagy-dependent mechanism. |
| In vitro | Anticancer agent 193 (D3-3; 2.5-30 μM; 12-48 h) inhibits HCT-116 cell proliferation with IC50 values of 15.06 μM, 11.18 μM, and 5.87 μM at 12, 24, and 48 hours, respectively. At concentrations of 5-20 μM over 12 hours, it significantly increases the ratio of autophagy marker proteins LC3B-II/LC3B-I and enhances the expression of ferritin subunit FTH1. Additionally, Anticancer agent 193 (D3-3) promotes the accumulation of lipid ROS and markedly increases divalent iron levels in a concentration-dependent manner in HCT-116 cells. |
| In vivo | Agent 193 (D3-3; 30-60 mg/kg; intraperitoneal injection; daily; for 2 weeks) inhibits tumor growth and enhances lipid peroxidation in the HCT-116 xenograft model. |
| Formula | C34H47ClN2O6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.